software sparkcontrol, v. 2.3 Search Results


cholesterol  (Croda International Plc)
96
Croda International Plc cholesterol
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Cholesterol, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/TopFluor+Cholesterol/pmc12905485-129-15-24
Average 96 stars, based on 1 article reviews
cholesterol - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
sodium lauryl polyethoxysulfate disponil® fes 27  (BASF)
90
BASF sodium lauryl polyethoxysulfate disponil® fes 27
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Sodium Lauryl Polyethoxysulfate Disponil® Fes 27, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/sodium+lauryl+polyethoxysulfate+disponil++fes+27/us10364379-47-29-39
Average 90 stars, based on 1 article reviews
sodium lauryl polyethoxysulfate disponil® fes 27 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
polymer vsl 5025-1  (Bayer AG)
90
Bayer AG polymer vsl 5025-1
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Polymer Vsl 5025 1, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/polymer+vsl+5025+1/us06984683-90-99-111
Average 90 stars, based on 1 article reviews
polymer vsl 5025-1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
locking  (Stryker)
86
Stryker locking
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Locking, supplied by Stryker, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/2+locking/pmc13038694-2-16-6
Average 86 stars, based on 1 article reviews
locking - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
p(bs-co-bf) ex 2.1  (BASF)
90
BASF p(bs-co-bf) ex 2.1
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
P(bs Co Bf) Ex 2.1, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/p+bs+co+bf++ex+2+1/us09217056-239-82-124
Average 90 stars, based on 1 article reviews
p(bs-co-bf) ex 2.1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
lignosulfonate sodium salt reax 88b  (Westvaco Inc)
90
Westvaco Inc lignosulfonate sodium salt reax 88b
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Lignosulfonate Sodium Salt Reax 88b, supplied by Westvaco Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/reax+++88b++sodium+lignosulfonate/us08383548-56-13-17
Average 90 stars, based on 1 article reviews
lignosulfonate sodium salt reax 88b - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
chrome steel beads biospec nc0605481  (BioSpec)
90
BioSpec chrome steel beads biospec nc0605481
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Chrome Steel Beads Biospec Nc0605481, supplied by BioSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/chrome+steel+beads+biospec+products/pmc11817774-100-13-14
Average 90 stars, based on 1 article reviews
chrome steel beads biospec nc0605481 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
murashige skoog plant salt mixture  (FUJIFILM)
90
FUJIFILM murashige skoog plant salt mixture
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Murashige Skoog Plant Salt Mixture, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/murashige+skoog+plant+salt+mixture/pmc11701795-193-3-9
Average 90 stars, based on 1 article reviews
murashige skoog plant salt mixture - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
swt 108 2.3 turbines  (Siemens AG)
90
Siemens AG swt 108 2.3 turbines
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Swt 108 2.3 Turbines, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/swt+108+2+3+turbines/10__1016_slash_j__ijepes__2022__108021-184-33-29
Average 90 stars, based on 1 article reviews
swt 108 2.3 turbines - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
protein halk1 fc  (Biacore)
86
Biacore protein halk1 fc
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
Protein Halk1 Fc, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/ace2+fc+preparation+protein/10__1158_slash_1535___7163__mct___09___0650-161-88-120
Average 86 stars, based on 1 article reviews
protein halk1 fc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
2.3-mm ophthalmic knife msl23  (MANI INC)
90
MANI INC 2.3-mm ophthalmic knife msl23
( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). <t>Cholesterol</t> efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.
2.3 Mm Ophthalmic Knife Msl23, supplied by MANI INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/slit+knife/pmc08832185-130-29-32
Average 90 stars, based on 1 article reviews
2.3-mm ophthalmic knife msl23 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
tsb medium  (Merck KGaA)
90
Merck KGaA tsb medium
Motility of V. anguillarum strains resistant to the CHOED phage. (A) Motility of resistant PF4-R8 strain (upper) and parental PF4 strain (lower). (B) Motility halo for each of the resistant strains. Tests were carried out in TSB medium supplemented with 0.4% agar and 2.3% <t>NaCl.</t> Cultures were incubated for 48 h <t>at</t> <t>25°C.</t> Error bars represent standard deviation of triplicates. The results of the strain marked ( ∗∗∗∗ ) are significantly different from the parent strain ( p < 0.0001).
Tsb Medium, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+sparkcontrol%2C+v%2E+2%2E3/tsb+medium/pmc06596326-95-24-17
Average 90 stars, based on 1 article reviews
tsb medium - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). Cholesterol efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.

Journal: Biochemical Journal

Article Title: Homocysteine thiolactone affects paraoxonase 1 activity via altered paraoxonase 1 distribution on high-density lipoprotein particles

doi: 10.1042/BSR20253768

Figure Lengend Snippet: ( A ) Relative PON1 activities in serum samples with HcyT treatment: arylesterase (ARE) activity; paraoxonase (PON) activity; thiolactonase (TLC) activity. Representative Western blots with densiometric quantification graphs of PON1 ( B, D ) and apoA-I ( C, E ) by Native-PAGE (0.34 µg HDL protein/lane). Cholesterol efflux capacity in serum samples with HcyT treatment ( F ). Samples were serum (45 mg HDL-C/dl) incubated with 0, 1, 10, and 20 mM HcyT at 37°C for 24 h. Samples were assayed in triplicate ( A, F ). Representative profiles from three independent experiments are shown ( B-E ). Data are presented as mean ± SD from three independent experiments ( A, F ). * P <0.05 determined by one-way analysis of variance with Tukey correction or Games–Howell correction. apoA-I, apolipoprotein A-I; CEC, cholesterol efflux capacity; HcyT, homocysteine thiolactone; n.s.; not significant; PON1, paraoxonase 1.

Article Snippet: Liposomes were formed by evaporating the chloroform containing 10.6 mg of lecithin, 2.3 mg of cholesterol, and 0.0075 mmol of 23-(dipyrrometheneboron difluoride)-24-norcholesterol (BODIPY-labeled cholesterol; Avanti Polar Lipids Inc., Alabaster, AL, U.S.A.) under a stream of N 2 gas.

Techniques: Activity Assay, Western Blot, Clear Native PAGE, Incubation

Motility of V. anguillarum strains resistant to the CHOED phage. (A) Motility of resistant PF4-R8 strain (upper) and parental PF4 strain (lower). (B) Motility halo for each of the resistant strains. Tests were carried out in TSB medium supplemented with 0.4% agar and 2.3% NaCl. Cultures were incubated for 48 h at 25°C. Error bars represent standard deviation of triplicates. The results of the strain marked ( ∗∗∗∗ ) are significantly different from the parent strain ( p < 0.0001).

Journal: Frontiers in Microbiology

Article Title: Diversification of Vibrio anguillarum Driven by the Bacteriophage CHOED

doi: 10.3389/fmicb.2019.01396

Figure Lengend Snippet: Motility of V. anguillarum strains resistant to the CHOED phage. (A) Motility of resistant PF4-R8 strain (upper) and parental PF4 strain (lower). (B) Motility halo for each of the resistant strains. Tests were carried out in TSB medium supplemented with 0.4% agar and 2.3% NaCl. Cultures were incubated for 48 h at 25°C. Error bars represent standard deviation of triplicates. The results of the strain marked ( ∗∗∗∗ ) are significantly different from the parent strain ( p < 0.0001).

Article Snippet: Resistant mutants and the PF4 strain were grown for 24 h at 25°C on plates with TSB (MerK) supplemented with 1.5% agar and 2.3% NaCl.

Techniques: Incubation, Standard Deviation